Literature DB >> 25096900

In vitro effect of H2O 2, some transition metals and hydroxyl radical produced via fenton and fenton-like reactions, on the catalytic activity of AChE and the hydrolysis of ACh.

Armando Méndez-Garrido1, Maricarmen Hernández-Rodríguez, Rafael Zamorano-Ulloa, José Correa-Basurto, Jessica Elena Mendieta-Wejebe, Daniel Ramírez-Rosales, Martha Cecilia Rosales-Hernández.   

Abstract

It is well known that the principal biomolecules involved in Alzheimer's disease (AD) are acetylcholinesterase (AChE), acetylcholine (ACh) and the amyloid beta peptide of 42 amino acid residues (Aβ42). ACh plays an important role in human memory and learning, but it is susceptible to hydrolysis by AChE, while the aggregation of Aβ42 forms oligomers and fibrils, which form senile plaques in the brain. The Aβ42 oligomers are able to produce hydrogen peroxide (H2O2), which reacts with metals (Fe(2+), Cu(2+), Cr(3+), Zn(2+), and Cd(2+)) present at high concentrations in the brain of AD patients, generating the hydroxyl radical ((·)OH) via Fenton (FR) and Fenton-like (FLR) reactions. This mechanism generates high levels of free radicals and, hence, oxidative stress, which has been correlated with the generation and progression of AD. Therefore, we have studied in vitro how AChE catalytic activity and ACh levels are affected by the presence of metals (Fe(3+), Cu(2+), Cr(3+), Zn(2+), and Cd(2+)), H2O2 (without Aβ42), and (·) OH radicals produced from FR and FLR. The results showed that the H2O2 and the metals do not modify the AChE catalytic activity, but the (·)OH radical causes a decrease in it. On the other hand, metals, H2O2 and (·)OH radicals, increase the ACh hydrolysis. This finding suggests that when H2O2, the metals and the (·)OH radicals are present, both, the AChE catalytic activity and ACh levels diminish. Furthermore, in the future it may be interesting to study whether these effects are observed when H2O2 is produced directly from Aβ42.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096900     DOI: 10.1007/s11064-014-1400-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  Acetylcholine. I. Hydrolysis by hydrogen and hydroxyl ion.

Authors:  J BUTTERWORTH; D D ELEY; G S STONE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

2.  Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia.

Authors:  Brian J Tabner; Omar M A El-Agnaf; Stuart Turnbull; Matthew J German; Katerina E Paleologou; Yoshihito Hayashi; Leanne J Cooper; Nigel J Fullwood; David Allsop
Journal:  J Biol Chem       Date:  2005-09-01       Impact factor: 5.157

3.  Carotenoids as scavengers of free radicals in a Fenton reaction: antioxidants or pro-oxidants?

Authors:  N E Polyakov; T V Leshina; T A Konovalova; L D Kispert
Journal:  Free Radic Biol Med       Date:  2001-08-01       Impact factor: 7.376

Review 4.  Metal chelation as a potential therapy for Alzheimer's disease.

Authors:  M P Cuajungco; K Y Fagét; X Huang; R E Tanzi; A I Bush
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 5.  Computer simulation of native epidermal enzyme structures in the presence and absence of hydrogen peroxide (H2O2): potential and pitfalls.

Authors:  Nicholas C J Gibbons; John M Wood; Hartmut Rokos; Karin U Schallreuter
Journal:  J Invest Dermatol       Date:  2006-12       Impact factor: 8.551

Review 6.  Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner.

Authors:  Karin U Schallreuter; Souna Elwary
Journal:  Life Sci       Date:  2007-01-25       Impact factor: 5.037

Review 7.  Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.

Authors:  D Allan Butterfield; Marzia Perluigi; Rukhsana Sultana
Journal:  Eur J Pharmacol       Date:  2006-06-15       Impact factor: 4.432

Review 8.  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Authors:  Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

9.  Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo.

Authors:  Karin U Schallreuter; Souna M A Elwary; Nicholas C J Gibbons; Hartmut Rokos; John M Wood
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

Review 10.  Metal dyshomeostasis and oxidative stress in Alzheimer's disease.

Authors:  Mark A Greenough; James Camakaris; Ashley I Bush
Journal:  Neurochem Int       Date:  2012-09-08       Impact factor: 3.921

View more
  5 in total

1.  New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease.

Authors:  Iohanan Daniel García Marín; Raúl Horacio Camarillo López; Oscar Aurelio Martínez; Itzia Irene Padilla-Martínez; José Correa-Basurto; Martha Cecilia Rosales-Hernández
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

2.  The Role of Oxidative Stress in Decreased Acetylcholinesterase Activity at the Neuromuscular Junction of the Diaphragm during Sepsis.

Authors:  Hua Liu; Jin Wu; Jun-Yan Yao; Hong Wang; Shi-Tong Li
Journal:  Oxid Med Cell Longev       Date:  2017-11-05       Impact factor: 6.543

3.  Changes in murine anorectum signaling across the life course.

Authors:  S Fidalgo; B A Patel; R N Ranson; M J Saffrey; M S Yeoman
Journal:  Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 3.598

4.  Tandem Molecular Self-Assembly Selectively Inhibits Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress.

Authors:  Debin Zheng; Yumiao Chen; Sifan Ai; Renshu Zhang; Zhengfeng Gao; Chunhui Liang; Li Cao; Yaoxia Chen; Zhangyong Hong; Yang Shi; Ling Wang; Xingyi Li; Zhimou Yang
Journal:  Research (Wash D C)       Date:  2019-12-03

5.  AChE-activity in critically ill patients with suspected septic encephalopathy: a prospective, single-centre study.

Authors:  Benedikt Zujalovic; Benjamin Mayer; Sebastian Hafner; Florian Balling; Eberhard Barth
Journal:  BMC Anesthesiol       Date:  2020-11-17       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.